Stock & Company Details
Merck & Co Inc $MRK
Price:
46,691,331
2.5B
$317B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
137.58
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
MRK technical indicators
Latest Merck & Co Inc (MRK) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
68.00 3.4%
MACD:
2.73 15.5%
SMA 50:
$116.31 0.2%
SMA 200:
$106.77 0.2%
EMA 20:
$120.89 0.7%
Bollinger Bands:
129 / 110
Stochastic:
95.51 2.1%
ADX 14:
19.95 7.0%
ATR 14:
3.31 0.7%
CCI 20:
166.45 17.1%
OBV:
404.55M 2.8%
ROC 12:
6.41% 25.8%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of its mission to save and improve lives. It demonstrates its commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals - including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases - as we aspire to be the premier research-intensive biopharmaceutical company in the world.
Finance Bot
Ask your questions
Start by typing a question below.
